August 5, 2013

Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.

November 19, 2012

The year 2012 is coming to an end, and it's been a big year for generic drugs. It's the year that the most lucrative drug of all time became commoditized. It's the year that Watson bought Actavis for $5.6 billion. And it's the year the FDA released draft guidance for biosimilars regulations. All of these events speak to some of the most important trends in the world of generics — trends that are often interrelated.

August 14, 2014

Pragma Pharmaceuticals announced the relaunch of Moxatag (amoxicillin extended-release tablets), 775 mg.

August 11, 2014

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

August 11, 2014

Twinlab Consolidation Corp. on Monday announced it has acquired Twinlab Corp. in a strategic, employee-led buyout. 

 

August 6, 2014

Walgreens said it has exercised its option to complete the second step of its strategic transaction with Alliance Boots ahead of the original option period, which was between February and August 2015.

 

July 30, 2014

Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.

July 28, 2014

Dollar Tree on Monday morning acquired Family Dollar Stores in a cash and stock transaction worth about $8.5 billion. 

 

July 21, 2014

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

July 17, 2014

UrgentRx on Thursday announced that it has closed on $17.5 million of Series C growth capital. 

July 16, 2014

Capsa Solutions, a provider of medication management systems, mobile computing carts and medical cart platforms for healthcare facilities, announced the acquisition of Kirby Lester, LLC — a provider of automated medication dispensing solutions in retail, institutional, hospital and ambulatory pharmacy settings.

July 14, 2014

CVS Caremark has announced that it has entered into an agreement to acquire the assets of Miami-based Navarro Discount Pharmacy.

July 14, 2014

Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business.

July 10, 2014

While sales of heat and ice packs are relatively flat — the category generated slight growth of 0.2% to $235.9 million for the 52 weeks ended April 20 across total U.S. multi-outlets, according to IRI — there has been some positive momentum within the category.

July 3, 2014

Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego. 

July 2, 2014

Kroger and Vitacost.com on Wednesday announced a definitive merger agreement under which Kroger will purchase all outstanding shares of Vitacost.com for $8 per share in cash, or approximately $280 million.

July 1, 2014

CytoSport Monday evening announced that it will be acquired by Hormel Foods Corporation.

June 23, 2014

Performance Health, the manufacturer and marketer behind TheraBand, Biofreeze, Perform, Cramer, Bon Vital' and Hygenic products, last week announced that it acquired TheraPearl, the creator of hot and cold therapy products.

June 12, 2014

In preparation for the grand re-opening of the Rite Aid located at 300 North Canon Dr. in Beverly Hills, the company on Thursday announced it will kick off the celebration by hosting 21 days of special events for customers.

June 9, 2014

Merck and Idenix Pharmaceuticals on Monday announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.

June 6, 2014

GelStat Corp. on Thursday announced it signed a definitive agreement to acquire Mastix Medica.

June 6, 2014

Henkel, a laundry and home care business, announced that it will acquire all shares in the Spotless Group in a transaction valued at 940 million euros (about $1.28 billion USD).

June 3, 2014

Teva Pharmaceutical and Labrys Biologics, a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, on Tuesday announced that Teva has entered into a definitive agreement to acquire Labrys in a deal for $200 million in upfront payment in cash at closing as well as up to $625 million in contingent payments upon achievement of certain pre-launch milestones.

May 29, 2014

Gov. Alejandro García Padilla on Wednesday announced an agreement by Puerto Rico Industrial Development Co. with Actavis that will allow the pharmaceutical manufacturer to develop a solid dosage manufacturing and packing facility in its Manati site and expand its current hormone production in Fajardo.